Data-driven Strategies for Advanced Cancer Care Delivery


In this enlightening podcast episode, Joy Kincaid, the Chief Product Officer of AccessHope, delves into the dynamic landscape of healthcare technology and its profound impact on cancer care. She shares insights into the rapid evolution of oncology, emphasizing the critical role of innovative technologies in revolutionizing treatment approaches. AccessHope, under Kincaid’s leadership, spearheads the mission of democratizing cancer care by harnessing the power of data to tailor optimal treatment pathways for patients.

Throughout the discussion, Kincaid navigates the challenges and triumphs inherent in implementing technology-driven products in healthcare. From safeguarding patient data to ensuring clinical quality and navigating the complexities of the healthcare system, AccessHope confronts these obstacles head-on, driven by a commitment to improving patient outcomes.

Looking ahead, Kincaid paints a compelling vision for the future of data-driven healthcare. She underscores the importance of effectively scaling products, maintaining quality standards, and enhancing access to care. However, amidst the technological advancements, Kincaid emphasizes the indispensable role of compassionate care, advocating for a harmonious balance between technology and human touch. In this vision, artificial intelligence emerges as a supportive co-pilot in healthcare delivery, augmenting the capabilities of healthcare professionals.

The podcast serves as a beacon of inspiration, highlighting the transformative potential of continuous innovation and personalized care in the realm of cancer treatment. Through the lens of AccessHope’s groundbreaking work, listeners gain a deeper appreciation for the pivotal role of technology in shaping the future of healthcare and enhancing patient well-being.

Key Moments


  • Technology has the power to rapidly change the world, especially in the healthcare sector.
  • The field of oncology is experiencing significant advancements due to AI and machine learning.
  • The healthcare system faces challenges in delivering quality care efficiently.

Joy Kincaid’s Background and Role

  • Joy Kincaid is the Chief Product Officer at AccessHope, with extensive experience in healthcare and technology.
  • AccessHope focuses on providing cancer support benefits and connecting members to leading cancer care experts.
  • Joy’s passion for technology drives product innovation at AccessHope to improve access to cancer care knowledge.

Personal and Professional Journey

  • Joy’s career journey started in management consulting and transitioned to the healthcare industry.
  • She shares her experiences in various healthcare sectors, including senior living, home health, and addiction and mental health.
  • Joy’s interest in healthcare technology led her to join AccessHope and focus on digital products for cancer care.

Human-Centered Design and Core Beliefs

  • Joy emphasizes the importance of human-centered design in developing patient-centered products.
  • AccessHope’s core mission is to democratize cancer care and leverage expertise from comprehensive cancer centers.
  • Balancing quality, scope, and time is crucial for product development in a startup environment.

Challenges and Opportunities in Healthcare Innovation

  • Challenges include protecting patient data, ensuring clinical quality, and navigating the complexity of the healthcare system.
  • AccessHope focuses on scaling its product effectively while maintaining high-quality care delivery.
  • Joy sees challenges as opportunities for growth and improvement in healthcare innovation.

The Role of AI in Cancer Care

  • AI can transform healthcare by enhancing efficiency and personalizing care delivery.
  • AI should complement, not replace, compassionate healthcare providers in making care decisions.
  • Joy highlights the need for continuous training and checks and balances when integrating AI into healthcare.

Future of Data-Driven Healthcare Innovations

  • Joy envisions expanding access to care, modernizing healthcare delivery, and simplifying the care process.
  • AccessHope aims to leverage technology to improve access to care and provide personalized cancer care.
  • The future holds opportunities for advancing data-driven innovations in healthcare to benefit more individuals affected by cancer.



Welcome to Digital Health Transformers, a podcast series. This podcast explores the dynamic world of healthcare innovation, one conversation at a time. I’m your host, Bryce Barger, and today, we have an all-inspiring guest at the forefront of transforming the healthcare landscape.

Today, we’ve invited a special guest, Joy Kincaid, the Chief Product Officer of Access Hope. Joy holds dynamic experience in the healthcare field, especially in oncology and surgical care. Her knowledge and work revolve around developing innovative technologies to modernize healthcare.

With almost two decades of experience in healthcare, Joy is regarded as a serial entrepreneur for her work in OncoHealth, WealthCare Health Plans, Optum, and even Accenture. Her passion for technology drives her product strategies and innovations. At Access Hope, she is responsible for innovating, designing, and building products that improve access to leading cancer care.

Knowledge for members and their doctors, Access Hope offers cancer support benefits for members. She connects them and their families to the expertise of subspecialists at the National Cancer Institute, a designated comprehensive cancer center. With a strategic approach, Access Hope brings the best cancer treatment expertise to help ensure the right treatment early on for the best possible outcomes. We are excited to welcome Joy and look forward to discussing how data-driven strategies help in advanced cancer care delivery.

Thanks for joining us today, Joy. How are you this afternoon?


I’m fantastic. How are you doing?


I am doing well. I am super excited about this, and this is such obviously a topic that hits close to kind of my heart as a past and current somebody dealing with skin cancer. Still, everybody has somebody who’s affected by this nowadays. So, this is such an awesome topic, and many of the listeners will be able to connect with this.

So, I’m super excited to have this conversation today. Me too.


I am honored to be here and represent Access Hope, and to your point, cancer is such a… Unfortunately, the statistics regarding how many lives it impacts and families are staggering.


Yes, ma’am. It is, and it’s something that is pushing, making sure that we continue to push the envelope forward and continue to strive for new strategies and better outcomes, especially since it’s so important to make sure that we don’t get stagnant in this, which I know doesn’t happen. Still, it’s such an important, really important step. I’m just starting here; I wanted to touch on your personal and professional story.

Joy, you have worked in healthcare for much of your career and pioneered several products. Could you take us on your journey?


Yeah. I’m happy to. I want to talk about one of the things I thought was interesting when I talked about my journey: how you got to where you are today and what those early lessons instilled in you.

One of the things I should have started in healthcare was that I dated myself and talked about where I started my career, which is a different industry. And then how I brought that into healthcare.

So, I am dating myself. But do you remember this thing before? There were mobile phones that we all have, there were long distances, and there was a home phone, and there were phones in your house. And, like, I remember that, on a Sunday, it was always like a Sunday morning.

We would get a phone call. My mom would say, Oh my gosh, it’s your uncle Bjorn or your grandma calling, and somebody called. And it was what we called then, you know, back then, you had a local calling, which is like calling your neighbor.

And then you had this concept of long distance, which was super expensive. The whole house stopped. Did you have that experience as a child?


For sure. Yes.


100%. Yeah. And so it’s. I want to bring that up because my first job was at your point in management consulting. It was around the turn of the century, and we were focused on improving the long-distance service for a giant telecommunications company.

I worked for about two years building this product while I was fortunate enough to ship it, be there when it got shipped, and be in the call center. At first call, I was sitting next to the agent, and the first call came. In. There was a disconnect, and they wanted mobile services. And then the second call came in, and it was another disconnect.

So, the next 20 calls were all to disconnect long distances. They didn’t want any of these features we built. And I, I, I, it was so terrifying, but it also, you’re like, what happens?




What happened? But like to your point, like it really, I’m happy it happened when it happened because it was my first engagement. And I learned two things.

One, Holy cow, rap, you know, technology can change the world in the blink of an eye. And this was the boom, and mobile phones were starting. And then two, you have to understand even, you know, I work today in cancer, which is a very complex space.

I’ve worked in healthcare, and those challenges are multiple, and the complexity levels are even more amplified. But even then, it’s like understanding your customer needs and what the problem is to solve. They didn’t want a widget to make it easier to buy long distance.

They wanted a comp, you know, convenient, and the next generation, the technology of mobile phones. So I like to start with that. But then from there, you know, I, I worked in electronics and high tech and eventually made my way into a startup, WellCare, which was doing government healthcare, which I went from electronics and high tech to healthcare and saw, I don’t know what your, what your first foray to healthcare, but this was my first foray.

We were trying to get people to enroll in new programs under the Clinton administration, like the prescription drug Part D program and children’s Medicaid, and we had to go door to door to gain access. This was before iPhones with laptops, gathering people’s input and collecting data. And I was just hooked.

I was like, I didn’t know that you could go into healthcare and not be a doctor. And there was this whole other side of healthcare, the world.




And I’d like to know how you got into healthcare in the early 2000s. And so it was more of an, um, like a newer field of managed care back then. And then eventually, you know, to your point, had opportunities to join Optum, had opportunities to get into ongoing health, but ultimately let us hear where it brings it all full circle, where we’re virtualizing, uh, cancer care and patient delivery and truly trying to help with some deep problems within the healthcare system.


So, yeah, yeah, for sure. I started, um, out of school. It was, um, diagnosed with diabetes when I was ten years old, and, uh, it was kind of like throwing like a bucket of water in my face.

And, but, I got super interested in healthcare and nurses. And I was in the hospital a lot. I had gone DKA multiple times as a child that spent, you know, days in the hospital and had seen that whole world, um, and, and lived in Houston, Texas, Houston, Texas at the time.

I was also at Texas Children’s Hospital, one of the nation’s top children’s hospitals. And I was around cutting-edge medicine, at least what it seemed to me, and I was fascinated by it. I remember I used to come home after, after high school, and would get myself, you know, grab my homework, get myself some snack, a Dorito, a ramen noodle, whatever I’d be eating, and turn on like TLC.

And they had, you know, the unexplained medical mysteries, just like these weird TV shows. And I would just be locked into it. So when I went to school after I graduated, I was like, I’m going to be a nurse.

Then, I’m going to be getting into anesthesiology. I love that aspect of being able to put someone to sleep and do surgery. Uh, I found out in college that I’m, I don’t, I, I I’m a very good talker.

I’m very good, but I need chemistry. I’m not math. I’m not that world much, much like my wife is.

And, uh, who’s a, who’s a, who’s a doctor herself. I found that out shortly after moving into business management, but I wanted to stay in the healthcare world. When I first got into my kind of school, I started working in the senior living field, um, and physical and occupational, as well as speech therapy for a company called Restore, and I fell in love with that.

And I moved it into home health and got into the home health side of things. Um, and then actually went into, uh, the addiction and mental health space. Um, uh, and was working on becoming a business development specialist for a company in Mississippi.

Um, I live in Birmingham, Alabama, and what was so cool about them is they have fought like dogs to get into the network with Alabama, Medicare, and Medicaid because the need in Alabama was so underserved. We have three hospitals here that can take inpatient help for addiction and mental health. Um, and we have a ton of outpatients.

As a lot of places have done about patients, but if you don’t have, you know, hard-line insurance for a lot of those, it’s, it’s tough. If you don’t have insurance, good luck getting inpatient care.




So, um, what, what my, uh, our CEO there was from Alabama originally and saw the need and got into, um, got us into the network, fought like a, fought like a dog, I’m sure. They got us into the network with Alabama, Medicare, and Medicaid, and we started servicing their patients. We were very close to the line and the state line and greatly impacted that.

Uh, it was so cool. And I, um, and kind of how I got into the digital space and the digital products and healthcare is, um, you know, there were so many needs in, uh, that I saw in the addiction and mental health space of being just being behind, you know, with their technologies that, um, I had, um, gotten in touch with OSP just as a, actually as a, as a way for them to build us a product, um, a kind of a practice management product for the hospital that would help us help our efficiency, help everything, help us track our patients, just kind of this whole thing. And, um, they did that.

When COVID happened and things slowed down, I got the opportunity to join OSP, and that’s how I came over to OSP.


Oh, that’s awesome.


Yeah. But it was, um, and now I’m seeing, I’ve now since I’ve been here for the years, I’ve been here, I’ve seen them, the impact technology is making in healthcare. Um, and it’s just now starting.

I know it’s been there for a long time, and I will not dim or discredit what anybody’s done in the past because of what’s got us here. Still, now with some of these AIs and machine learnings and these, and these, uh, all these products, we’re starting to approach a new cusp, um, and it’s such an exciting thing. And that’s kind of access hopes, kind of, um, approach to your guises, uh, to that digital, digital health strategy for cancer and digital-driven strategies, I should say. And, um, super excited to have this conversation and kind of, um, shed some light on kind of some of the challenges you faced in finding kind of the right way to develop a patient kind of patient-centric products or like, uh, you know, uh, and kind of help, help, help fill us in on that a little bit.


Yeah. Yeah. Yeah.

I have been fortunate to have developed several patient-centered products, over a dozen, in the last couple of decades. Here’s what I’ve learned. First of all, I learned that, you know, I’m not. Are you familiar with human-centered design? Still, I have a passion and purpose for human-centered design, starting with a problem statement and being extraordinarily curious about the true pain point. What are you here to solve?

And then two, I blend that with this approach of thinking that when you work for a company, it’s important to understand your mission. Then what are what I call core beliefs and access hope? For example, to your point, our core mission is to democratize cancer care, export the knowledge from the NCI comprehensive cancer centers, the six foundational partners that we work with, which are the City of Hope, Dana Farber, Emory, the Hutchins, Fred Hutch, Northwestern and Johns Hopkins.

That is a core belief that you know is core to who our company is. It’s timeless. And so that knowing that helps anchor how you build those products and how you, I don’t want to use the word scope, but you know, it’s timeless.

It’s not; it’s a timeless belief. The third thing is especially relevant as you look at startups: we are approximately four years old. Um, you need to. When you build new products or with existing products, I’ll start on the building of new products.

You have to build ship early, and often, you’re always balancing three things: quality, which quality can be synonymous with obviously the quality of care, the quality of evidence-based clinical pathways, as well as beautiful product design and making sure it’s easy, easy to use from a user perspective because that is vital in healthcare. Um, my mom just got hearing aids, and we went through and found the most advanced hearing aid that was also digitally connected to her smartphone. And she loves it, and it’s changed her life.

Thankfully, she was able to see that modernizations are happening. You have to keep it super complex and monitor accessibility and scope. Then, your most expensive thing is scope and time as a startup.

Can you get a product to market and then learn and adjust? And so that’s the final piece: you’re looking at everything as a learning process and journey, because what I love about healthcare, and you said it, we’ve come a long way, but we’re also in a way in the first inning. I agree with you that if you compare where there’s been so much technological advancement,

AI is so exciting, but a lot of what has been done to date has been what I like: softer events in marketing, email, and video; the harder problems are harder to solve, and they, understandably, will lag. So, that’s how I look at the patient-centered approach. The other thing we do here, and I bring everywhere I go, is everybody talks to the customers and the users.

It’s about finding Venn diagrams because I live in a B2B2C world, which means business to business to consumer. So, the buyer, for the most part, is an enterprise company, like a large employer that can self-fund their population. And, but we’re treating consumers, and for us, we’re working with oncologists directly as well.

So everybody’s in the field speaking to, you know, where they can speak to oncologists, everybody’s we do user testing at least every two weeks, if not weekly, and everyone tests. It’s not just something a designer does. Everyone in the team does that.

Everyone who joins my team is encouraged to go out into the field and, uh, what our growth teams do and sit down with our clients. Those are the things that I do to keep it super relevant, contemporary, and constantly current. I hate to say it, not the anxiety, but the anxiety of, like, how can I do more for the, you know, keeping it real.

And I think sometimes it’s really easy to get behind the numbers and not remember at the end of the day that these are people with cancer. One of the scariest diagnoses in the world. And, you know, how, how can we keep remembering that empathy portion of it?

So that’s how I do it. It’s been very successful. I also believe in design, meaning you must have a beautifully designed product you’re proud of.


Yeah, I love that. And I think, I think, um, speaking to kind of that point is making sure that you, um, once you get to a certain point that you are staying connected, um, to the patient, staying connected to your bait to, to kind of where you started, um, and not losing, not, not losing, um, not starting cutting quarters for numbers or for, which is easier said than done. Right.

A lot of times, because of the business side, it is also hard to do. You have to be able to run a successful business to do these things. So it’s fantastic to hear that you’re so aware of that.

Cause a lot of, um, when you get to the, to the topper C-suites that it’s easy, it’s super easy for them to get disconnected. Right. You hear that, you hear that all the time, and it’s true, um, that because it’s not, it’s not out of, you know, choice by them or anything.

They’re just busy; they have many other things to care for. Um, so that’s such a great thing to hear. And when you’re, and when you’re dealing with someone, something like cancer, like you’re mentioning is, um, hearing that, hearing that the whole company’s bought into, um, not, not just making my experience better, but also innovating and taking the next step to, to, to help even more is so cool to hear.

It’s cool to hear.


I would add just one thing, a couple of things about the Access Hope culture that I would highlight. That’s the reason why I joined Access Hope. We do something every day, so we have town halls once a quarter or once, excuse me, once a month, regularly once a month. We end every town hall, and I gave major credit to Access Hope because they had this before I joined.

I’ve been here a little, about 15 months. At the end of every town hall, they do what’s called a member spotlight, and it’s de-identified. But one of our doctors will come on and talk about, you know, the story of a member, how we helped that member, what their original diagnosis was, what the treating oncologist said when they spoke to them because our doctors will speak to the treating oncologist to consult them on their care path. And every town hall, that’s what we do.

We have a member spotlight for every client meeting. And it’s so core to what we are because, you know, we’re just a company, and that’s why I thoroughly enjoyed my time at Access Hope. It’s a mission-driven organization at its core and heart, permeating the company.


Right. I love that. I do.

So, I am getting into the role of data in today’s healthcare. As that role evolves, how will it personalize the care, specifically in oncology?


Yeah. Um, so let’s talk about data. What is data?

So, let’s unpack that question. So data. So what Access Hope is here to do, and you talked about it, I’ll keep kind of reinforcing it is we’re here exporting knowledge from, so what we do today, our service, our offering is we are exporting knowledge from those foundational partners into the community oncologists to help people get on the optimal care pathway.

We can discuss why some problems must be solved and how we exist. But when you take, break that into pieces, data is bits of information. And when you string that together, it’s knowledge.

And so whether that’s medical records, that of the patient that we work with those on founding on those on college founding on partners to work with them, to, um, summarize that information and then be able to send a beautifully written, uh, report to the treating oncologist and then speak to them about it. You know, that’s how we use data to change care delivery. And I’ll tell you a little about the care delivery problems we’re solving and how that knowledge and data work together.

So, in the space of oncology, it’s a rapidly evolving field. Uh, about, it used to be medical knowledge that changed every 50 years. It’s now down to 73 days since it changed, which is fantastic that oncology is progressing that fast. Unfortunately, the unintended consequence is that there are times when the guidelines lag because of the pace of change.

Therefore, we focus on optimal care in the areas where we can provide the most value, which is rapidly evolving within oncology. And then three, I would say, you know, to what we talked about, um, unfortunate, you know, cancer is a human journey and most people, 84%. I was talking to a friend today about this, but 84% of people do not get a second opinion when they’re going through the cancer journey. And so what we do is we work with employers, health plans, and, uh, also what we call channel partners like aggregators or navigators to identify people that we can help collect their medical records in a process that is extraordinary like takes the burden off of the member that’s going through something and their family that’s going through something very, uh, challenging.

Then, we work with Johns Hopkins, the city of hopes, and the six NCI centers to find the subspecialty that would be best for that person’s case. Then, we share that with the oncologist, and we do that all in a virtual setting. We do that through technology that’s in power, that’s powering that whole process.

So that’s how I see data. And that’s just the beginning. We’re a company that’s four years in, um, we have a tremendous opportunity to help people even more with this hyper-personalized care.

Um, but that’s how we change care delivery by getting people on the optimal treatment path and exporting that knowledge into the community. Does that help answer the question?


Yeah, definitely. No, no, it does. OSP. We worked on similar data-driven patient care projects.

Um, and obviously, there are multiple challenges, even just delivering that care and data. What challenges do you see that affect healthcare, innovation, and patient care?


So there’s a couple of things. One is the protection of patient data is patient data. The safety of recommendations, right?

Making sure we have the utmost clinical quality. Um, and then I would, but I would also say just the realities of the healthcare system and the size we are dealing with all the different groups to deliver this care and simplify what we’re trying to do. For example, when we have to collect medical records, we have to go to medical records, departments, labs, and all these different groups to collect all the medical records.

That is a very complex process. Um, we have to work through engagement with those treating oncologists. So there are a lot of challenges to pulling this together and taking a system that is all well-intended, but try to optimize it, you know, for that individual patient and pull all those pieces apart.

I’m thinking of a good analogy based on the breadth and scope of our system. If you think about it, I’m trying to think like restaurants; there are many providers. There are so many, and there are 14,000 different oncologists.

They’re all across the country. There’s a lot of breadth and scope when you think about everything you have to pull together to get a patient on the optimal care journey.


So, there are many moving parts in the process, and having something like Access Hope to help with that is massive and important. It’s, it’s, um, um, not only for, to provide better outcomes for as far as the doctor, the physician, but also the patient themselves being able to under for understanding for ease of use for all of these things, all the challenges that, that the patient faces that also, um, to help the doctors overcome the challenge, those challenges, which, you know, and, and healthy efficiency of, um, of care, which, which, which we’ve already seen leads to better outcomes.

So, we’ve seen that the proof’s in the pudding for this proof. Uh, and, um, you know, so, so, so, so viably important. Getting into kind of some of the technology advanced cancer care delivery.

As we’ve discussed before, new emerging technologies, like AI, VR, machine learning, et cetera, have given health providers um and innovators a lot of hope. Do you, for one, do you agree with that kind of statement, and how do you think these technologies will impact cancer care shortly?


Yeah. So, one, AI will be a transformative capability. Um, we talked about this briefly.

I also think healthcare is still adopting things digitally and, you know, getting, um, getting to move beyond what was it? Getting to move beyond, you know, traditional methods of telephone as well as faxing. I know you do because your podcast is named after it. But yeah, like I look at it as, to your point, I think AI is, the hype around AI is extraordinarily justified.

When you, you know, if I look across my career, there was the 2000s, which was the dot-com bubble. You saw great companies like Google, Amazon, and Meta emerge. Then you saw the inflection point of mobile and the iPhone.

Then you saw Airbnb, you know, a whole new set of use cases added between ride-sharing and Airbnb. And now we’re at this third inflection point, which is AI. And AI has so much promise.

We have been looking at different ways, proof of concepts within the AI space since chat GPT-3 was unveiled, or was it four? It was a lot; four was the big milestone. We had been playing with it with three, and then four was the big milestone.

For many of what I say, more of the back office functions to automate and structure data and identify things. But where it’s just the beginning of what its potential is. And it’s just a huge inflection point that folks need to, that will not go away.

It’s a real hype. That being said, there is still, there will always be a need for a compassionate doctor. AI will be more of a co-pilot to help within this care delivery space in the next few years.

It won’t replace the compassionate doctor. No one wants to be told that they have cancer by a machine like that’s not compassion.

And so, that’s my perspective. And that is my perspective. So, where I see it, we’re at the beginning of an amazing series of the next five years, which will have the magic in the use cases that people will create on top of these models.

So yeah, I’m extraordinarily excited. One of the things that I’ve heard a lot about recently, yet haven’t seen in detail, is you continue to hear if you, I don’t know how much you listen to Sam Altman speak, but you hear him talk about what they’re doing with scientific progress and that became his goal. It will be amazing to see what happens because of the incumbents and the very large language models; it will be amazing to see what they end up doing and if they can solve the computing issues.

That’s for sure.


A hundred percent. And I agree with that statement. I also discussed the podcast we still need to release with Adam Montmorcy.

We were speaking on a similar question, asking me about AI and moving from helping with efficiencies to more patient-centered care, making care choices, and care delivery. He said that, and I agreed wholeheartedly that there was always a need for a checks and balances system for even AI. And you put it perfectly where it should only be and never really be used as a tool to help the physician make better choices and outcomes for the patient.

It should never be a replacement. For a physician, it’s definitely, but the technology is nowhere near that. People get so hyped that AI is here, and now we can; it can do everything, but it isn’t.

It’s. Still, it’s exciting, and we’re taking huge steps, but there’s a long way to go before we’re to the point where it’s being truly involved, or ever has been, in the question of replacing a position, a doctor, or anything. Right.


I agree with you. I see that you want to; you have to be thoughtful that it will continue to prove at a hundred acts to your point. However, when we play with and have been doing our protocol for conception, it’s doing many more normalized items very easily.

But when you get into the specific oncology use cases, not about recommend date, doing any medical care, but being able to that those specific use cases with that are unique to our field, you see a gap, and where the model can’t handle, it’s not trained on that. And so when you’re thinking about building with AI, it’s to your point: you’ll always have a doctor in the loop. You’re always going to. There is a level of investment in training because it won’t go full.

It needs to be at a state of maturity to take it to the next level. It is really exciting, though, because even personally, I’m now using it for my son, who had an injury, and we had to take him to the ER. And I asked one of these models to please price out.

If I have an x-ray, a child at this hospital, yes, at this hospital, and I’m covered by this insurance. What do you think? How much is this going to cost me? It came back with a number, and I’m waiting for the EOB to see if it’s accurate.


So, I might need to set a reminder and email you after to figure out what that is. That’s a great use case.


Yeah. So we’ll see, we’ll see if it does. It came out true.


So that’s interesting. I, I love that. Can you share some? I have written this question down as a challenge, but it could be. Could you share some challenges or successes that Access Hope has faced in implementing some of these technology-driven products for cancer care?


I see the word challenges as opportunities, right? And so, the opportunity where we are as a company is that we are a growth-stage company. We have over 5 million members.

We have over 400 customers of varying degrees and sizes. And where we’re at is how we continue to scale the product effectively and where we place those bets. Right.

How do we scale the product effectively? And then this is the challenge that most healthcare companies have to wrestle with because you have this, you, you cannot, there’s no room for error. Right.

And so there are so many phenomenal clinicians that are doing everything amazing. So, how do you find the right balance of self-service as well? Giving people options and access to care as well as, you know, maintaining the highest quality possible.

So that’s the opportunity for us that lies ahead. How do you effectively scale? You know, how do we continue to scale this product that has product market fit across with increasing demand as we keep going?


Joy, I appreciate your time. I have final thoughts here. And the last question I have is where, and this is broad. Where do you foresee the next frontier in data-driven healthcare innovations and improvements in cancer care?

What do you, what do you see as Access Hopes’s next dream or next step? What do you, what, what do you kind of, what’s in your wishlist?


Yeah. Where I see the next revolution is continuing. We can help more people.

I think the complexities of care continue to grow and grow. More people are living with cancer than there are people with active cancer. There are, you know. We started with the working age with self-funded employers.

There’s a tremendous opportunity to go more broadly across the spectrum of care. I’m super excited when I think of the future with Access Hope. When I think about healthcare specifically, just like we just talked about, there is so much potential to continue to improve access to care, modernize care, and make it simpler from where we started, right?

You are an inpatient working in hospitals to provide care to people more conveniently and cost-effectively, increasing access and care. That’s what excites me. I hope that you know the tech will continue to help with that care delivery and make it more accessible to people across the country.

And, as much as we talk about the healthcare system in America, there are other populations in the world, you know, who even have more need for virtual care. So I’m excited, and I’m an internal optimist. My name is Joy.

So, it comes with the territory. And I, you know, I enjoy you as well. Your persona and your happiness radiate from you and your optimism.

I appreciate having had an opportunity to talk to you today, be a part of this podcast, and discuss the great things ahead of us.


Yeah, I, I, that is ditto Joy. I really can see the passion. And every time I love, I love having conversations with healthcare companies, pushing the box forward and pushing innovation.

And there is a common thread of hope, of being, of just being, that things can improve. And I’m going to be the person to make it better. Yeah.

Which is what I love. I see that in a trend, and you have that as well. And it’s such an, and, and being able to have you in this space, you know, make some, as somebody who’s, who’s dealing with cancer, literally right now, going to a doctor’s appointment in the next.


I know I was going to ask, are you okay?


I am, I am doing good. Everything’s, everything’s going fine. So we’ll be; everything is going well.

So I will; I’m still fighting, and I know that technologies and companies like Access Hope and yourself are behind that. It’s just, it’s just cool. It is.

And it’s exciting to know that, you know what, we’re not stagnant in this. We’re not just accepting it. We have people out here fighting every day for people like me, for people like your brother, for people like your mother, for people like everybody out there who’s been affected by cancer.

So, from my half and OSP’s half, I send my thank you to you, Access Hope, and thank you for what you guys are doing. So, thank you again for your time. And I cannot wait to stay in touch with you guys and see what’s happening next year with Access Hope.


Awesome. I love that. And I wish you the best of luck.

It has been my honor and pleasure to talk to you today. So I know you have to get your appointment, so I’ll let you go, but I’m happy to come back and share more about what we’re doing next year. So, yes, ma’am.


Thank you so much, Drew.


All right. Thank you.




Talk to you later. Bye-bye.

Sign up to get updates for podcast

By signing up, you agree to receive email from this podcast

Recent Podcasts

Addressing Social Determinants Through Digital Health Ft Aaron de Montmorency

In this episode of Digital Health Transformers, host Bryce Barger welcomes Aaron DeMontmourcy, Director of IT Security and Compliance at Elevate Health, to discuss the intersection of IT security and healthcare innovation. Aaron shares his journey from the US Army to Elevate Health, highlighting the importance of cybersecurity in the healthcare sector. The conversation explores topics such as social determinants of health (SDOH), digital health tools for underserved populations, and the role of emerging technologies like machine learning and AI in healthcare. Join Bryce and Aaron as they delve into the transformative potential of digital health in addressing healthcare disparities and improving patient outcomes.

Empowering Healthcare Providers With Technology Ft Karen Serrago

In this insightful podcast, Karen Serago, CTO of Community Technology Cooperative (CTC), shares her expertise in implementing Epic EHR systems and leveraging technology to enhance patient care in Federally Qualified Health Centers (FQHCs). She discusses the challenges faced during Epic implementations and how CTC’s strong governance process mitigates them. Karen highlights the emerging roles of AI and data analytics in fostering health equity, reducing administrative burdens, and enabling personalized care. The conversation explores how technologies like interoperability, patient portals, and speech-to-text solutions revolutionize care delivery and improve patient outcomes while addressing data privacy concerns.

Leveraging Digital Health to Expand Philanthropic Reach Ft Dzenan Berberovic

In this episode of the Digital Health Transformers podcast, host Nicole interviews Dzenan Berberovic, the Chief Philanthropy Officer of Avera Health. Dzenan shares his inspiring journey from being a first-generation college graduate to leading philanthropic efforts in healthcare. He discusses the pivotal role of philanthropy in shaping patient care and access to services, emphasizing how donations enhance healthcare experiences. Dzenan also highlights the strategic influence of philanthropy on healthcare organizations, detailing how it drives future initiatives and programs. Furthermore, he explores the utilization of technology to streamline processes and ensure data security in philanthropic operations. Overall, the episode underscores the importance of supporting local hospitals and healthcare systems through philanthropy.

About the Guest


Joy Kincaid linkedin

Joy Kincaid holds dynamic experience in the healthcare field, especially in oncological and surgical care. Her knowledge and work revolve around developing innovative technologies to modernize healthcare. With almost two decades of experience in healthcare, Joy is regarded as a serial entrepreneur for her work in OncoHealth, WellCare Health Plans, Optum, and Accenture. Her passion for technology drives her product strategies and innovations. At AccessHope, she is responsible for inventing, designing, and building products that improve cancer treatments for patients.

Like what you are reading? Share this blog.

You Might Also Like

Latest Talks


10 Rapidly Growing Medicine Specialities to Look for in 2022

Read More Hear

10 Exclusive Dashboards for Healthcare Decision Makers

Read More Hear

Health Leadership Insights: Making Digital Health Profitable

Read More Hear

The Future of Connected Health: Challenges & Strategies Ahead

Read More Hear